TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER

This adverse event was reported 94 times

These drugs are most commonly taken by patients reporting TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER:

# Drug Count
0 LENALIDOMIDE 8
1 DEXAMETHASONE 6
2 DEXAMETHASONE 1.5 MG 6
3 METHOTREXATE SODIUM 5
4 OMEPRAZOLE 5
5 OMEPRAZOLE MAGNESIUM 5
6 TACROLIMUS 5
7 TACROLIMUS EXTENDED-RELEASE CAPSULES 5
8 TACROLIMUS OINTMENT 0.1% 5
9 VALSARTAN 5
See all common drugs associated with TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER

TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FENOFIBRIC ACID 2 0.0026
1 BACILLUS CALMETTE-GUERIN 3 0.0017
2 ENFORTUMAB VEDOTIN 2 0.0003
3 ABACAVIR SULFATE 2 0.0002
4 SIROLIMUS 2 0.0001
5 ATAZANAVIR 2 0.0001
6 RITONAVIR 100 MG 2 0.0001
7 ORLISTAT 3 0.0001
8 LINAGLIPTIN 2 0.0001
9 ERGOCALCIFEROL 3 0.0001
See all drugs enriched for association with TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER